Binocularly Asymmetric Crowding in Glaucoma and a Lack of Binocular Summation in Crowding.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
03 01 2022
Historique:
entrez: 27 1 2022
pubmed: 28 1 2022
medline: 19 2 2022
Statut: ppublish

Résumé

Glaucoma is associated with progressive loss of retinal ganglion cells. Here we investigated the impact of glaucomatous damage on monocular and binocular crowding in parafoveal vision. We also examined the binocular summation of crowding to see if crowding is alleviated under binocular viewing. The study design included 40 individuals with glaucoma and 24 age-similar normal cohorts. For each subject, the magnitude of crowding was determined by the extent of crowding zone. Crowding zone measurements were made binocularly in parafoveal vision (i.e., at 2° and 4° retinal eccentricities) visual field. For a subgroup of glaucoma subjects (n = 17), crowding zone was also measured monocularly for each eye. Our results showed that, compared with normal cohorts, individuals with glaucoma exhibited significantly larger crowding-enlargement of crowding zone (an increase by 21%; P < 0.01). Moreover, we also observed a lack of binocular summation (i.e., a binocular ratio of 1): binocular crowding was determined by the better eye. Hence, our results did not provide evidence supporting binocular summation of crowding in glaucomatous vision. Our findings show that crowding is exacerbated in parafoveal vision in glaucoma and binocularly asymmetric glaucoma seems to induce binocularly asymmetric crowding. Furthermore, the lack of binocular summation for crowding observed in glaucomatous vision combined with the lack of binocular summation reported in a previous study on normal healthy vision support the view that crowding may start in the early stages of visual processing, at least before the process of binocular integration takes place.

Identifiants

pubmed: 35084432
pii: 2778313
doi: 10.1167/iovs.63.1.36
pmc: PMC8802025
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

36

Subventions

Organisme : NEI NIH HHS
ID : R01 EY027857
Pays : United States

Références

Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3827-3836
pubmed: 30737290
Exp Brain Res. 1968;6(4):391-410
pubmed: 5721767
Invest Ophthalmol Vis Sci. 2012 Nov 15;53(12):7655-65
pubmed: 23074213
Nat Neurosci. 2001 Jul;4(7):739-44
pubmed: 11426231
Curr Opin Ophthalmol. 2009 Mar;20(2):92-8
pubmed: 19240541
J Vis. 2007 Oct 26;7(2):21.1-17
pubmed: 18217836
Ophthalmology. 2014 Aug;121(8):1655-62.e1
pubmed: 24768243
Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5332-8
pubmed: 17962490
Nat Neurosci. 2011 Aug 14;14(9):1195-201
pubmed: 21841776
Trends Cogn Sci. 2011 Apr;15(4):160-8
pubmed: 21420894
Arch Ophthalmol. 1984 Mar;102(3):363-70
pubmed: 6703983
Invest Ophthalmol Vis Sci. 2011 Feb 16;52(2):940-6
pubmed: 20881293
Nippon Ganka Gakkai Zasshi. 2006 Nov;110(11):914-8
pubmed: 17134038
Nature. 1970 Apr 11;226(5241):177-8
pubmed: 5437004
Curr Biol. 2015 Dec 21;25(24):3213-9
pubmed: 26628010
Sci Rep. 2017 Aug 15;7(1):8271
pubmed: 28811585
Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6473-82
pubmed: 26447981
Ophthalmology. 2013 Apr;120(4):736-44
pubmed: 23246120
Arch Ophthalmol. 1999 Apr;117(4):450-4
pubmed: 10206571
Vision Res. 1981;21(3):329-36
pubmed: 7269310
Ophthalmology. 2008 Jun;115(6):941-948.e1
pubmed: 17997485
Sci Rep. 2021 Mar 1;11(1):4843
pubmed: 33649371
J R Soc Interface. 2015 Feb 6;12(103):
pubmed: 25505132
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):13130-5
pubmed: 19617570
J Glaucoma. 2021 Feb 1;30(2):140-147
pubmed: 33074958
Vision Res. 1984;24(4):385-94
pubmed: 6740959
Nat Neurosci. 2008 Oct;11(10):1129-35
pubmed: 18828191
J Neurophysiol. 2014 Nov 15;112(10):2413-22
pubmed: 25122703
Vision Res. 2007 Jun;47(14):1950-62
pubmed: 17502115
Surv Ophthalmol. 1989 Feb;33 Suppl:309-18
pubmed: 2655144
Arch Ophthalmol. 2009 Jul;127(7):875-81
pubmed: 19597108
Ophthalmology. 2014 Dec;121(12):2371-9
pubmed: 25148790
Transl Vis Sci Technol. 2012 May 25;1(1):3
pubmed: 23626924
Br J Math Stat Psychol. 1965 May;18:1-10
pubmed: 14324842
Prog Retin Eye Res. 2013 Jan;32:1-21
pubmed: 22995953
Percept Psychophys. 1981 Sep;30(3):266-76
pubmed: 7322802
J Opt Soc Am A Opt Image Sci Vis. 1997 Sep;14(9):2057-68
pubmed: 9291601
Percept Psychophys. 1991 Jun;49(6):495-508
pubmed: 1857623
Transl Vis Sci Technol. 2015 Nov 30;4(6):4
pubmed: 26644964
Invest Ophthalmol Vis Sci. 2017 Nov 1;58(13):5810-5818
pubmed: 29131903
J Ophthalmol. 2014;2014:120528
pubmed: 24883203
Invest Ophthalmol Vis Sci. 2014 Feb 03;55(2):632-49
pubmed: 24370831
Vision Res. 1992 Jul;32(7):1349-57
pubmed: 1455707
Invest Ophthalmol Vis Sci. 2012 Jun 14;53(7):3629-37
pubmed: 22511628
Arch Ophthalmol. 2004 Apr;122(4):532-8
pubmed: 15078671
Vis Neurosci. 2006 Jan-Feb;23(1):137-42
pubmed: 16597357
J Vis. 2004 Dec 30;4(12):1136-69
pubmed: 15669917
J Vis. 2006 Oct 13;6(11):1159-71
pubmed: 17209726
Front Hum Neurosci. 2019 Jul 12;13:234
pubmed: 31354452
Invest Ophthalmol Vis Sci. 2021 Jan 4;62(1):5
pubmed: 33393971
Atten Percept Psychophys. 2012 Feb;74(2):379-96
pubmed: 22160819
J Vis. 2014 May 05;14(5):3
pubmed: 24799622
Curr Opin Neurobiol. 2008 Aug;18(4):445-51
pubmed: 18835355
Nat Neurosci. 2012 Jan 08;15(3):463-9, S1-2
pubmed: 22231425
Spat Vis. 1997;10(4):437-42
pubmed: 9176953
Trans Am Ophthalmol Soc. 1984;82:792-826
pubmed: 6398938
J Vis. 2013 Jun 24;13(7):14
pubmed: 23798030
Invest Ophthalmol Vis Sci. 2003 Jul;44(7):3005-10
pubmed: 12824245
Br J Ophthalmol. 2015 Sep;99(9):1236-9
pubmed: 25802251
Br J Ophthalmol. 1999 May;83(5):546-52
pubmed: 10216052
Neuroimage. 2014 Jun;93 Pt 1:23-31
pubmed: 24582921
Invest Ophthalmol Vis Sci. 1991 Nov;32(12):3091-5
pubmed: 1938283
Vision Res. 2008 Feb;48(5):635-54
pubmed: 18226828
J Physiol. 1967 Nov;193(2):327-42
pubmed: 6065881
Invest Ophthalmol Vis Sci. 2019 Feb 1;60(2):538-543
pubmed: 30716149
J Vis. 2009 Nov 19;9(12):13.1-18
pubmed: 20053104
Invest Ophthalmol Vis Sci. 2008 May;49(5):1907-15
pubmed: 18436824
Invest Ophthalmol Vis Sci. 2015 Jan 27;:
pubmed: 25626974
Arch Ophthalmol. 1982 Jan;100(1):135-46
pubmed: 7055464
Spat Vis. 1997;10(4):433-6
pubmed: 9176952
Arch Ophthalmol. 1999 Jan;117(1):24-33
pubmed: 9930157
Nature. 1996 Sep 26;383(6598):334-7
pubmed: 8848045
Nature. 1965 Oct 9;208(5006):191-2
pubmed: 5884255
J Vis. 2002;2(2):140-66
pubmed: 12678589
Invest Ophthalmol Vis Sci. 2013 Jan 23;54(1):666-72
pubmed: 23074207
Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6221-6231
pubmed: 29228250
Optom Vis Sci. 2012 Sep;89(9):1282-7
pubmed: 22885786
PLoS One. 2012;7(4):e35829
pubmed: 22558234
Spat Vis. 1994;8(2):255-79
pubmed: 7993878
Invest Ophthalmol Vis Sci. 2014 Jul 22;55(8):5284-90
pubmed: 25052992
Vision Res. 2013 Apr 19;82:42-51
pubmed: 23485426
J Vis. 2007 Oct 26;7(2):20.1-36
pubmed: 18217835
Vision Res. 1985;25(7):979-91
pubmed: 4049747
Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6540-8
pubmed: 20671278

Auteurs

Foroogh Shamsi (F)

Department of Psychology, Northeastern University, Boston, Massachusetts, United States.

Rong Liu (R)

Department of Psychology, Northeastern University, Boston, Massachusetts, United States.
Department of Ophthalmology and Visual Sciences, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.
Department of Life Science and Medicine, University of Science and Technology of China, Hefei, China.

MiYoung Kwon (M)

Department of Psychology, Northeastern University, Boston, Massachusetts, United States.
Department of Ophthalmology and Visual Sciences, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH